The company will hold a conference call for analysts/institutional investors on Tuesday, November 17, 2026, at 4:00 p.m. IST to discuss operational and financial performance for the quarter and half year ended September 30, 2026 (Q2 & H1 FY27).
The meeting was originally scheduled for November 18, 2026 (Wednesday) but has been preponed by one day to November 17, 2026 (Tuesday).
The stated purpose is to discuss the company's operational and financial performance for Q2 and H1 FY27.
Management participants include: Mr. Vikram Kelkar (Managing Director), Dr. Nikhil Kelkar (Jt Managing Director), and Mr. Soman Jana (Chief Financial Officer).
The company explicitly states that no Unpublished Price Sensitive Information (UPSI) will be shared during the meeting.
The disclosure does not include any financial highlights, guidance references, or presentation summaries within the announcement text.
Additional Notes Section
The document includes access details for the conference call with multiple dial-in numbers: Primary numbers (+91 22 6280 1102, +91 22 7115 8003) and toll-free numbers for USA (1-866-746-2133), UK (0-808-101-1573), Singapore (800-101-2045), and Hong Kong (800-964-448).
A Diamond Pass registration link is provided: https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=0667002&linkSecurityString=5e3204302
The disclosure will be available on the company's website at www.hexagonnutrition.com
No financial data or performance figures were disclosed in this announcement.
The document is signed by Ms. Vedanti Vartak, Company Secretary & Compliance Officer (Membership: A41580).
